Radiation Therapy in Oncology
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 30 June 2026 | Viewed by 572
Special Issue Editor
Special Issue Information
Dear Colleagues,
We are pleased to invite you to contribute to the upcoming Special Issue of Cancers, titled "Radiation Therapy in Oncology", which aims to explore current trends, innovations, and strategies in contemporary cancer treatment.
Despite being one of the most effective modalities in oncology, the full potential of radiation therapy has yet to be realized. This Special Issue will focus on recent advances in treatment strategies, particularly those that employ multimodal and individualized approaches across various types of cancer. We are especially interested in original research and reviews that evaluate the tolerability and efficacy of combined therapies both in prospective and retrospective settings. Additionally, submissions showcasing technological innovations in radiation therapy are highly encouraged.
Your expertise will significantly enhance the scientific value and impact of this Special Issue. As such, we invite you to share your latest research with the Cancers community.
We look forward to receiving your contributions.
Prof. Dr. Jerzy Wydmański
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- radiotherapy
- radiation injury
- systemic therapy
- immunotherapy
- cancer
- concurrent chemoradiotherapy
- stereotactic radiotherapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
